ABioVaxys Technology Corp: BioVaxys Announces Results from The Ohio State University Pan-Sarbecovirus Animal Study
VANCOUVER, BC, Dec. 16, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced today that possibly based on the selected study